drugset

drugset / Trial / NCT03804476

Phase 1 Study to Assess AER-271

NCT03804476 ↗

Phase 1 Completed 80 enrolled Aeromics, Inc. Covance · collab

RandomizedSequentialQuadruple-blindTreatment

Summary

The objective of this Phase 1 trial is to assess the safety, tolerability and pharmacokinetics of AER-271 in health subjects.

Timeline

Start: 2018-06-26
Primary completion: 2019-07-18
Completion: 2019-08-28

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AER-271	Unknown	—	Intravenous

Indications